Age-Associated Hematological Toxicity in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel in Clinical Practice.

Marie-Rose B S CrombagAurelia H M de Vries SchultinkJacobine G C van DoremalenHans-Martin OttenAndries M BergmanJan H M SchellensJos H BeijnenAlwin D R Huitema

Published in: Drugs & aging (2019)

The risk of hematological toxicity was significantly higher in the oldest age quartile than in younger patients with mCRPC treated with docetaxel in daily clinical practice.

Keyphrases

clinical practice
oxidative stress
locally advanced
physical activity
newly diagnosed
squamous cell carcinoma
radiation therapy
rectal cancer